DESTINA Genomica SL

Well done, Antonio Marín Romero! We thoroughly enjoyed your excellent talk. DESTINA Genomica SL presented its investment opportunity at Alhambra Venture 2024. We were excited to participate once again at this 2024 edition and demonstrate our unique technology to the investment community.

DESTINA Genomica is the only company capable of directly detecting small RNA without the need for laborious and inefficient processes such as extraction and amplification. Furthermore, its technology enables the development of assays that can simultaneously detect proteins and nucleic acids. There is an interesting article about DESTINA Genomica today in the #IDEAL. Our CEO, Juan Jose Diaz-Mochon, illustrates the challenges and extraordinary opportunities emerging since we received an exceptional Seal of Excellence from the EU Commission for our LiverAce test. https://lnkd.in/dBhQT98z

Great talk by Piero Conca from #COGENTECH Catania at BIC Granada while visiting DESTINA GENOMICA. Piero is currently on his secondment at UGR as part of our EU #MarieCurie RISE project #diaRNAgnosis. It was nice learning how AI can support biomarker discovery.

We are delighted to announce our latest publication! Special thanks to the diaRNAgnos consortia for their collaboration and the Marie Curie funding program for their support. Stay tuned for more updates! #Research #Publication #Collaboration #MarieCurie #RISE #diaRNAgnos https://lnkd.in/dxj_HytZ

Great time, great company, and most importantly, great opportunities to explore. #GaliciaBiodays2024 | Vigo, 🇪🇸

Exciting news! DESTINA is attending Galicia Biodays 2024! 🚀 We’re looking forward to exploring new opportunities and opening a new chapter in our journey. #GaliciaBiodays2024 #DESTINA #Biotech #Innovation

Happy International Women's Day! 🌹Today at Manuel de Falla High School (Maracena, Spain), we celebrated with Salvatore Pernagallo Pernagallo and Bahareh Soleimanpour Soleimanpour, who gave an inspiring talk about the incredible women leading the charge in science. They presented our contribution to fight against colorectal cancer, highlighting the groundbreaking work of ColoMARK. We hope it was inspiring for the many interested students at the institute who may soon join our efforts by pursuing careers in science. Once again, cheers to the women who contribute to science every day with their brilliance and determination! 💪 #InternationalWomensDay #WomenInScience #ColonCancer ColoMARK DN

At DESTINA, our daily work is fueled by passion and guided by a shared vision. We're not just a team, but a community united in our pursuit of excellence and innovation. Every project is an opportunity to embrace challenges, grow together, and make a meaningful impact. Our diverse perspectives enrich our journey, pushing us towards our common horizon. Thank you to everyone who is part of this journey. Your passion and support make all the difference. Together, let's continue to turn our shared vision into reality. #DESTINA #Passion #Vision #Innovation

Indeed, it was a great event where new ideas and innovations for xMAP were presented. See below our winning poster 👇 https://lnkd.in/dBDDbs7G

Join us at #xMAPConnect to explore how COMBO LiverAce is revolutionizing the field of liquid biopsies. Witness the future of personalized medicine as we aim to enhance drug safety protocols. #PrecisionMedicine #HealthTech Luminex Corporation - A Diasorin Company AIT Austrian Institute of Technology